Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) [Phase 2]
Phase 2 trial evaluating intratumoral Hiltonol (poly-ICLC) for solid tumors was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) [Phase 3]
Phase 3 trial comparing S1 generic with capecitabine in metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing docetaxel plus fulvestrant versus docetaxel alone in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Clinical trial update about a breath test used in women receiving tamoxifen for breast cancer prevention or treatment; the study was termina…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. [Phase 3]
Phase 3 trial comparing pegfilgrastim-gema to pegfilgrastim-roche for prevention of induced neutropenia in breast cancer patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial on individualized treatment for locally advanced breast cancer based on tumor molecular characteristic…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab plus irinotecan in HER2-positive metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer [Phase 2]
Phase 2 prospective multicenter observational trial evaluating apatinib alone or with capecitabine for metastatic HER2-negative breast cance…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Neoadjuvant Endocrine Therapy in Breast Cancer [Phase 2]
A Phase 2 trial update evaluating neoadjuvant endocrine therapy in highly endocrine-responsive operable breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
A phase 2 trial evaluating carboplatin with combination chemotherapy, with or without veliparib, in patients with stage IIB–IIIC breast canc…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer [Phase 2]
Phase 2 trial update comparing two nab-paclitaxel doses in elderly patients with advanced breast cancer; results on efficacy and functional …
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer [Phase 2]
A randomized phase II study evaluating pre-operative celecoxib treatment in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer [Phase 3]
A Phase 3 clinical trial comparing aromatase inhibitors plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for postmenopau…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer [NA]
This terminated trial evaluated Cu-64 TP3805 as a PET imaging agent in breast cancer, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer [Phase 3]
Phase 3 trial evaluating Pertuzumab added to chemotherapy and Trastuzumab as adjuvant therapy for HER2-positive primary breast cancer; resul…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating the effects of zoledronate on bone mineral density in postmenopausal women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Study for Using Radiosurgery on Limited Metastases of Breast Cancer [NA]
A completed clinical trial evaluating the use of radiosurgery for limited metastatic breast cancer with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-02Clinical Trial Update: Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients. [Phase 3]
Phase 3 clinical study update for Nanogen Pegcyte in preventing CIN in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: KVUS at Neoadjuvant CTx of Breast Cancer [Phase 3]
Phase 3 clinical trial update for KVUS with neoadjuvant chemotherapy in early primary breast cancer (status unknown).
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. [Phase 3]
Phase 3 trial comparing Olaparib monotherapy to physician's choice chemotherapy in metastatic breast cancer patients with germline BRCA1/2 m…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating doxorubicin and cyclophosphamide followed by docetaxel with lapatinib in stage II/III HER2-positive bre…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating bicalutamide in combination with aromatase inhibitors for ER-positive, AR-positive, HER2-negative metastatic breast…
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Survival TRaining for ENhancing Total Health (STRENGTH) [Phase 2]
Phase 2 clinical trial update for STRENGTH study evaluating survival training for overall health in breast cancer and depression populations…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer [Phase 2, Phase 3]
A clinical trial update exploring the risk and clinical benefit of chemotherapy and intensive endocrine therapy for Luminal B1 early-stage b…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Standard Versus Continuous Capecitabine in Advanced Breast Cancer [Phase 2, Phase 3]
This document reports the completion of a Phase 2/3 trial comparing standard versus continuous capecitabine in metastatic breast cancer, wit…